Agilon Health Faces NYSE Delisting Notice
I'm PortAI, I can summarize articles.
Agilon Health (AGL) received a delisting notice from the NYSE due to its stock price falling below $1.00 per share for 30 days. The company plans to pursue a reverse stock split, pending stockholder approval, to regain compliance. Analysts rate AGL as a Hold with a $0.50 price target, reflecting significant financial challenges. Despite some positive initiatives, declining revenues and negative profitability metrics weigh heavily on its stock score. Agilon Health focuses on transforming healthcare for seniors through a value-based care model.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments